538 related articles for article (PubMed ID: 22895339)
1. Passenger deletions generate therapeutic vulnerabilities in cancer.
Muller FL; Colla S; Aquilanti E; Manzo VE; Genovese G; Lee J; Eisenson D; Narurkar R; Deng P; Nezi L; Lee MA; Hu B; Hu J; Sahin E; Ong D; Fletcher-Sananikone E; Ho D; Kwong L; Brennan C; Wang YA; Chin L; DePinho RA
Nature; 2012 Aug; 488(7411):337-42. PubMed ID: 22895339
[TBL] [Abstract][Full Text] [Related]
2. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Lin YH; Satani N; Hammoudi N; Yan VC; Barekatain Y; Khadka S; Ackroyd JJ; Georgiou DK; Pham CD; Arthur K; Maxwell D; Peng Z; Leonard PG; Czako B; Pisaneschi F; Mandal P; Sun Y; Zielinski R; Pando SC; Wang X; Tran T; Xu Q; Wu Q; Jiang Y; Kang Z; Asara JM; Priebe W; Bornmann W; Marszalek JR; DePinho RA; Muller FL
Nat Metab; 2020 Dec; 2(12):1413-1426. PubMed ID: 33230295
[TBL] [Abstract][Full Text] [Related]
3. Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.
Su X; Chen S; Lu H; Li H; Qin C
Drug Des Devel Ther; 2021; 15():2769-2781. PubMed ID: 34234410
[TBL] [Abstract][Full Text] [Related]
4. Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of
Yan VC; Pham CD; Ballato ES; Yang KL; Arthur K; Khadka S; Barekatain Y; Shrestha P; Tran T; Poral AH; Washington M; Raghavan S; Czako B; Pisaneschi F; Lin YH; Satani N; Hammoudi N; Ackroyd JJ; Georgiou DK; Millward SW; Muller FL
J Med Chem; 2022 Oct; 65(20):13813-13832. PubMed ID: 36251833
[TBL] [Abstract][Full Text] [Related]
5. Cancer: Exploiting collateral damage.
Lehner B; Park S
Nature; 2012 Aug; 488(7411):284-5. PubMed ID: 22895327
[No Abstract] [Full Text] [Related]
6. Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
Sanzey M; Abdul Rahim SA; Oudin A; Dirkse A; Kaoma T; Vallar L; Herold-Mende C; Bjerkvig R; Golebiewska A; Niclou SP
PLoS One; 2015; 10(5):e0123544. PubMed ID: 25932951
[TBL] [Abstract][Full Text] [Related]
7. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
8. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated ENO1 promotes the bladder cancer cell growth and proliferation via regulating β-catenin.
Ji M; Wang Z; Chen J; Gu L; Chen M; Ding Y; Liu T
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431517
[TBL] [Abstract][Full Text] [Related]
10. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival.
Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q
J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of a 1p36 chromosomal duplication and in utero interference define ENO1 as a candidate gene for polymicrogyria.
El Waly B; Mignon-Ravix C; Cacciagli P; Buhler E; Ben Zeev B; Villard L
Eur J Hum Genet; 2020 Dec; 28(12):1703-1713. PubMed ID: 32488097
[TBL] [Abstract][Full Text] [Related]
12. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.
Qian X; Xu W; Xu J; Shi Q; Li J; Weng Y; Jiang Z; Feng L; Wang X; Zhou J; Jin H
Oncotarget; 2017 Jul; 8(29):47691-47708. PubMed ID: 28548950
[TBL] [Abstract][Full Text] [Related]
13. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
Zheng F; Jang WC; Fung FK; Lo AC; Wong IY
PLoS One; 2016; 11(2):e0147961. PubMed ID: 26882120
[TBL] [Abstract][Full Text] [Related]
14. Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma.
Zhu X; Yu H; Li B; Quan J; Zeng Z; Li G; Liu J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 30541900
[TBL] [Abstract][Full Text] [Related]
15. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
16. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.
Chen S; Zhang Y; Wang H; Zeng YY; Li Z; Li ML; Li FF; You J; Zhang ZM; Tzeng CM
Cell Death Dis; 2018 Mar; 9(3):347. PubMed ID: 29497031
[TBL] [Abstract][Full Text] [Related]
17. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1).
Feo S; Arcuri D; Piddini E; Passantino R; Giallongo A
FEBS Lett; 2000 May; 473(1):47-52. PubMed ID: 10802057
[TBL] [Abstract][Full Text] [Related]
18. [Small interfering RNA-mediated α-enolase knockdown suppresses glycolysis and proliferation of human glioma U251 cells in vitro].
Luo QS; Fu HD; Huang HN; Huang HD; Luo KX; Li CY; Qin CJ; Li XY; Luo HC; Wang JL; Tang QL
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1484-1488. PubMed ID: 29180328
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest.
Capello M; Ferri-Borgogno S; Riganti C; Chattaragada MS; Principe M; Roux C; Zhou W; Petricoin EF; Cappello P; Novelli F
Oncotarget; 2016 Feb; 7(5):5598-612. PubMed ID: 26734996
[TBL] [Abstract][Full Text] [Related]
20. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
